Advances in Study on Mesenchymal Stem Cells in Treatment of Inflammatory Bowel Disease
10.3969/j.issn.1008-7125.2018.02.009
- VernacularTitle:间充质干细胞在炎症性肠病治疗中的研究进展
- Author:
Yuming WANG
1
;
Xiaoqi ZHANG
;
Chenggong YU
Author Information
1. 南京大学医学院附属鼓楼医院消化内科,210008
- Keywords:
Inflammatory Bowel Disease;
Mesenchymal Stem Cells;
Mechanism;
Therapy
- From:
Chinese Journal of Gastroenterology
2018;23(2):101-104
- CountryChina
- Language:Chinese
-
Abstract:
Inflammatory bowel disease(IBD)is a non-specific,chronic intestinal inflammatory disease,and the pathogenesis of IBD is not completely clear. Mesenchymal stem cell(MSC)is a kind of pluripotent stem cell,which has the function of homing,tissue repair and immunomodulation. The therapeutic effects of MSC in systemic lupus erythematosus,graft-versus-host disease,myocardial infarction and some other diseases have been confirmed. Recent studies have shown that MSC has a unique advantage in the treatment of IBD. This article reviewed the advances in study on MSC in the treatment of IBD.
